购物车
- 全部删除
- 您的购物车当前为空
GSK854 是一种具有高选择性和有效性的肌钙蛋白 I 相互作用激酶 (TNNI3K) 抑制剂,抑制小鼠心肌梗死损伤细胞焦亡和细胞凋亡,可限制缺血性心脏的氧化应激、损伤和不良重塑。
为众多的药物研发团队赋能,
让新药发现更简单!
GSK854 是一种具有高选择性和有效性的肌钙蛋白 I 相互作用激酶 (TNNI3K) 抑制剂,抑制小鼠心肌梗死损伤细胞焦亡和细胞凋亡,可限制缺血性心脏的氧化应激、损伤和不良重塑。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 1,470 | 现货 | |
5 mg | ¥ 2,490 | 现货 | |
10 mg | ¥ 3,990 | 现货 | |
25 mg | ¥ 7,890 | 现货 | |
50 mg | ¥ 10,600 | 现货 | |
100 mg | ¥ 14,300 | 现货 | |
500 mg | ¥ 28,800 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 2,730 | 现货 |
产品描述 | GSK854 is a highly selective and potent inhibitor of troponin I interacting kinase (TNNI3K) that inhibits myocardial infarction-injured cellular pyroptosis and apoptosis in mice, which may limit oxidative stress, injury, and adverse remodeling in the ischemic heart. |
别名 | GSK-854, GSK 854 |
分子量 | 482.96 |
分子式 | C18H19ClN6O4S2 |
CAS No. | 1316059-00-3 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 100 mg/mL (207.06 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.